For 28 years, the Tissue Procurement Shared Resource (TPSR), rated in the last two CCSG reviews as """"""""outstanding"""""""", has been an important component of the research mission in the OSUCCC. The TPSR procures and provides malignant and normal tissues from solid tumors to the OSUCCC membership. The TPSR is part of a large tissue bank network at OSU entitled, """"""""The Human Tissue Resource Network"""""""" thal also includes: The NCI-funded Cooperative Human Tissue Network, the NCI-funded Cancer and Leukemia Group B (CALGB) Pathology Coordinating Office and specimen banks, the NCI-funded AIDS Malignancy Bank, the Tissue Archives Services and the Research Histology Core Facility. The strong institutional and coordinated support of groups compliments the TPSR to bring together the expertise and tools to direct tissue resource projects such as to enhance the support of the OSUCCC. The operation management and technical staff provide high quality and consistent tissue specimens that will likely prove critical to all six of the OSUCCC scientific programs. This service has been primarily a prospective tissue procurement service for basic science applications. However there is now a new effort to include pre-surgical (biopsy) and postsurgical collection of specimens for the purposes of clinical correlative studies by OSUCCC investigators. The TPSR efficiently accomplishes both basic science and clinical collection of materials that are fundamentally different yet both important to the goals of the OSUCCC. The TPSR staff provides quality control of the research specimen and direct interaction with pathologists and OSUCCC investigators to better assist in procurement of tissues and to foster hypothesis-driven cancer research. The TPSR has been used by five of the OSUCCC scientific programs with heavy use from the Molecular Biology and Cancer Genetics Program. All (100%) of the TPSR procurement usage is by OSUCCC members and 69.5% of the Laser Capture Microdissection activity has been by OSUCCC members, yet over the past four years only 65% of it's funding came from the CCSG. The TPSR seeks to continue to leverage strong institutional support of its services to provide for the expanding future needs for the OSUCCC. Indeed, in this application the CCSG support represents only 21.6% of the total TPSR cost. The collaboration between the hospitals, OSUCCC and the Department of Pathology to provide this service is demonstration of true synergy that adds ample value to the OSUCCC membership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-34
Application #
7743466
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2010-11-30
Support Year
34
Fiscal Year
2009
Total Cost
$264,603
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Shu, Yi; Yin, Hongran; Rajabi, Mehdi et al. (2018) RNA-based micelles: A novel platform for paclitaxel loading and delivery. J Control Release 276:17-29
Scoville, Steven D; Nalin, Ansel P; Chen, Luxi et al. (2018) Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood 132:1792-1804
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Schimizzi, Gregory V; Jin, Linda X; Davidson 4th, Jesse T et al. (2018) Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB (Oxford) 20:332-339
Fu, Xinping; Tao, Lihua; Wang, Pin-Yi et al. (2018) Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles. Oncotarget 9:21348-21358
Brewington, Beatrice Y; Shao, Yusra F; Davidorf, Fredrick H et al. (2018) Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions. Clin Ophthalmol 12:925-934
Doogan, Nathan J; Cooper, Sarah; Quisenberry, Amanda J et al. (2018) The role of travel distance and price promotions in tobacco product purchase quantity. Health Place 51:151-157
Byrd, John C; Ruppert, Amy S; Heerema, Nyla A et al. (2018) Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). Blood Adv 2:1705-1718
Oblinger, Janet L; Burns, Sarah S; Huang, Jie et al. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol 299:299-307
Pan, Pan; Oshima, Kiyoko; Huang, Yi-Wen et al. (2018) Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. Int J Cancer 143:886-896

Showing the most recent 10 out of 2602 publications